PBH
Prestige Consumer Healthcare Inc · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website restigebrands.com
- Employees(FY) 560
- ISIN US74112D1019
Performance
-5.81%
1W
-4.54%
1M
+6.49%
3M
+21.18%
6M
+28.59%
YTD
+29.84%
1Y
Profile
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Technical Analysis of PBH 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-17 19:00
PBH: Lowering target price to $84.00(Argus Research)
- 2024-12-10 19:00
PBH: Lowering target price to $88.00(Argus Research)
- 2024-12-09 06:39
- 2024-12-03 19:00
PBH: Raising target price to $89.00(Argus Research)
- 2024-11-26 19:00
PBH: What does Argus have to say about PBH?(Argus Research)
- 2024-11-12 19:00
PBH: Raising target price to $86.00(Argus Research)
- 2024-11-11 12:00
- 2024-11-10 07:24
- 2024-11-08 02:13
- 2024-11-07 11:12
Analyst Report: Prestige Consumer Healthcare Inc.(Morningstar Research)
- 2024-11-07 06:00
- 2024-11-07 05:47
- 2024-11-06 19:09
Analyst Report: Prestige Consumer Healthcare Inc.(Morningstar Research)
- 2024-11-06 17:00
- 2024-11-06 07:09
- 2024-11-05 19:00
PBH: Raising target price to $79.00(Argus Research)
- 2024-10-10 20:58
- 2024-10-09 17:34
- 2024-10-08 20:00
PBH: Lowering target price to $72.00(Argus Research)
- 2024-10-08 08:00
- 2024-10-07 20:00
- 2024-09-20 08:50
- 2024-09-17 08:00
- 2024-09-16 20:00
- 2024-09-04 08:50
- 2024-09-03 08:00
- 2024-09-02 20:00
- 2024-08-27 20:00
PBH: Raising target price to $76.00(Argus Research)
- 2024-08-20 20:00
PBH: Raising target price to $73.00(Argus Research)
- 2024-08-11 08:53
Page 1 of 7
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.